the study found people who had diagnosed heart failure or ischemic heart disease were about two times more likely to have a stimulant toxicity death compared to an opioid toxicity death. people who died of stimulant toxicity also visited healthcare more frequently for cardiovascular disease compared to people who died of opioid toxicity.
“people using stimulants appear to have more cardiovascular disease, and healthcare providers should be screening them for such conditions,” study co-author dr. frank scheuermeyer, an emergency room physician at st. paul’s hospital and program head for emergency medicine at the centre for advancing health outcomes, said in the release.
bc centre for disease control british columbia also points out that as of september 2024, 15,602 people have died from unregulated drug poisoning in the province since the toxic drug crisis was declared a public health emergency in 2016. unregulated drug toxicity is the leading cause of death in b.c. for people aged 10 to 59.
but how can doctors determine if someone is at risk of overdose if substance use isn’t discussed?
“people who use drugs often don’t feel safe disclosing their substance use to healthcare providers,” beth haywood noted in the release. haywood is a member of a peep, a provincial peer advisory group of people with lived experience of substance use, and peer project coordinator with island health. “we need to work to destigmatize these conversations, so people can get the services they need. primary care is a place where this can start.”
having conversations about the steps people can take to reduce drug-related health risks and the harm reduction tools that are available to them can help to reduce stigma around substance use. there’s also a push from the study authors to identify more opportunities for targeted interventions to reduce drug toxicity deaths among people who use substances and who have medical comorbidities. and given the numbers of people impacted, more research into the association between chronic disease, stimulant use and the risk of death due to drug toxicity is needed.